Research links development of childhood leukaemia to mistakes by the immune system

by University of LeedsA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaGenetic mutations that drive the

Updated on: July 02,2024

Research links development of childhood leukaemia to mistakes by the immune system

by University of LeedsA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaGenetic mutations that drive the

Updated on:July 02,2024

Researchers report new approach to treating incurable leukemia in children

by University of ZurichFrequent and often incurable: Child with acute lymphoblastic leukemia. Credit: University Children’s Hospital ZurichAcute lymphoblastic leukemia is the most common form of

Updated on: July 02,2024

Researchers report new approach to treating incurable leukemia in children

by University of ZurichFrequent and often incurable: Child with acute lymphoblastic leukemia. Credit: University Children’s Hospital ZurichAcute lymphoblastic leukemia is the most common form of

Updated on:July 02,2024

Study shows how morphine may contribute to bone loss and cancer-induced bone pain

by Stacy Pigott,University of ArizonaOn the left, cells isolated from breast cancer cells were treated with RANKL, a growth factor that stimulates bone resorption, to produce osteoclasts (pink).

Updated on: January 22,2024

Study shows how morphine may contribute to bone loss and cancer-induced bone pain

by Stacy Pigott,University of ArizonaOn the left, cells isolated from breast cancer cells were treated with RANKL, a growth factor that stimulates bone resorption, to produce osteoclasts (pink).

Updated on:January 22,2024

Meningioma molecular profile reliably predicts tumor recurrence

by Baylor College of MedicineCredit: CC0 Public DomainAlthough typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The

Updated on: March 12,2024

Meningioma molecular profile reliably predicts tumor recurrence

by Baylor College of MedicineCredit: CC0 Public DomainAlthough typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The

Updated on:March 12,2024

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos

Updated on: December 01,2024

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos

Updated on:December 01,2024

Blood cancers: Expert explains what you need to know

by Robin FosterBlood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says.First, bloo

Updated on: November 10,2024

Blood cancers: Expert explains what you need to know

by Robin FosterBlood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says.First, bloo

Updated on:November 10,2024

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class

Updated on: February 23,2024

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class

Updated on:February 23,2024

Drug combination shows promise in preclinical models of triple negative breast cancer

by Alhaji Janneh,Medical University of South CarolinaYueying Liu and Dr. Antonio Giordano study PLK1 inhibitors, traffic light-like signals that stop the uncontrolled growth of breast cancer cel

Updated on: May 23,2024

Drug combination shows promise in preclinical models of triple negative breast cancer

by Alhaji Janneh,Medical University of South CarolinaYueying Liu and Dr. Antonio Giordano study PLK1 inhibitors, traffic light-like signals that stop the uncontrolled growth of breast cancer cel

Updated on:May 23,2024

Are the benefits of new cancer drugs worth the cost?

by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef

Updated on: January 12,2024

Are the benefits of new cancer drugs worth the cost?

by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef

Updated on:January 12,2024

Creating a 'parts list' for cancer's spread, with help from a worm

by Duke UniversityA tiny worm cell breaking through the wall that normally holds cells in place. Credit:Development(2023). DOI: 10.1242/dev.201570What makes some cancer cells stay put

Updated on: January 30,2024

Creating a 'parts list' for cancer's spread, with help from a worm

by Duke UniversityA tiny worm cell breaking through the wall that normally holds cells in place. Credit:Development(2023). DOI: 10.1242/dev.201570What makes some cancer cells stay put

Updated on:January 30,2024

Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of

Updated on: April 23,2024

Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of

Updated on:April 23,2024

Firefighters far more likely to die from cancer and heart attacks than the public, finds study

by University of Central LancashireCredit: Pixabay/CC0 Public DomainA new study commissioned by the Fire Brigades Union (FBU) and independently carried out by the University of Central Lancashire

Updated on: February 18,2024

Firefighters far more likely to die from cancer and heart attacks than the public, finds study

by University of Central LancashireCredit: Pixabay/CC0 Public DomainA new study commissioned by the Fire Brigades Union (FBU) and independently carried out by the University of Central Lancashire

Updated on:February 18,2024